Incidence and risk factors for carbapenem- and multidrug-resistant Acinetobacter baumannii bacteremia in hematopoietic stem cell transplantation recipients

References

• Kuo LC, Lai CC, Liao CH, Hsu CK, Chang YL, Chang CY, et al. Multidrug-resistant Acinetobacter baumannii bacteraemia: clinical features, antimicrobial therapy and outcome. Clin Microbiol Infect 2007;13:196–8.
   PubMed Web of Science ®Google Scholar
• Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008;21:538–82.
   PubMed Web of Science ®Google Scholar
• Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 2008;46:1254–63.
   PubMed Web of Science ®Google Scholar
• Playford EG, Craig JC, Iredell JR. Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences. J Hosp Infect 2007;65:204–11.
   PubMed Web of Science ®Google Scholar
• Oliveira AL, de Souza M, Carvalho-Dias VM, Ruiz MA, Silla L, Tanaka PY, et al. Epidemiology of bacteremia and factors associated with multi-drug-resistant Gram-negative bacteremia in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2007;39:775–81.
   PubMed Web of Science ®Google Scholar
• Garnica M, Maiolino A, Nucci M. Factors associated with bacteremia due to multidrug-resistant Gram-negative bacilli in hematopoietic stem cell transplant recipients. Braz J Med Biol Res 2009;42:289–93.
   PubMed Web of Science ®Google Scholar
• Chan PC, Huang LM, Lin HC, Chang LY, Chen ML, Lu CY, et al. Control of an outbreak of pandrug-resistant Acinetobacter baumannii colonization and infection in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2007;28:423–9.
   PubMedGoogle Scholar
• Zhong L, Men TY, Li H, Peng ZH, Gu Y, Ding X, et al. Multidrug-resistant Gram-negative bacterial infections after liver transplantation—spectrum and risk factors. J Infect 2012;64:299–310.
   PubMedGoogle Scholar
• Patel G, Perez F, Bonomo RA. Carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii: assessing their impact on organ transplantation. Curr Opin Organ Transplant 2010;15:676–682.
   PubMedGoogle Scholar
• Candel FJ, Calvo N, Head J, Sanchez A, Matesanz M, Culebras E, et al. A combination of tigecycline, colistin, and meropenem against multidrug-resistant Acinetobacter baumannii bacteremia in a renal transplant recipient: pharmacodynamic and microbiological aspects. Rev Esp Quimioter 2010;23:103–8.
   PubMed Web of Science ®Google Scholar
• Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Oh MD, et al. Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome. Clin Infect Dis 2004;39:812–8.
   PubMed Web of Science ®Google Scholar
• Michalopoulos A, Falagas ME, Karatza DC, Alexandropoulou P, Papadakis E, Gregorakos L, et al. Epidemiologic, clinical characteristics, and risk factors for adverse outcome in multiresistant Gram-negative primary bacteremia of critically ill patients. Am J Infect Control 2011;39:396–400.
   PubMed Web of Science ®Google Scholar
• Lee K, Yong D, Jeong SH, Chong Y. Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogens. Yonsei Med J 2011;52:879–91.
   PubMed Web of Science ®Google Scholar
• Malone L, Kwon DH. Carbapenem-associated multidrug-resistant Acinetobacter baumannii are sensitised by aztreonam in combination with polyamines. Int J Antimicrob Agents 2013;41:70–74.
   PubMedGoogle Scholar
• Falagas ME, Koletsi PK, Bliziotis IA. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J Med Microbiol 2006;55:1619–29.
   PubMed Web of Science ®Google Scholar
• Paterson DL, Doi Y. A step closer to extreme drug resistance (XDR) in Gram-negative bacilli. Clin Infect Dis 2007; 45:1179–81.
   PubMed Web of Science ®Google Scholar
• Peffault de Latour R, Calado RT, Busson M, Abrams J, Adoui N, Robin M, et al. Age-adjusted recipient pretransplantation telomere length and treatment-related mortality after hematopoietic stem cell transplantation. Blood 2012;120:3353–9.
   PubMedGoogle Scholar
• Jimenez-Zepeda VH, Trudel S, Reece DE, Chen C, Rabea AM, Kukreti V. Cyclophosphamide and prednisone induction followed by cyclophosphamide mobilization effectively decreases the incidence of engraftment syndrome in patients with POEMS syndrome who undergo stem cell transplantation. Am J Hematol 2011;86:873–5.
   PubMed Web of Science ®Google Scholar
• Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995;15:825–8.
   PubMed Web of Science ®Google Scholar
• Rowlings PA, Przepiorka D, Klein JP, Gale RP, Passweg JR, Henslee-Downey PJ, et al. IBMTR severity index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol 1997;97:855–64.
   PubMed Web of Science ®Google Scholar
• Drew WL. Laboratory diagnosis of cytomegalovirus infection and disease in immunocompromised patients. Curr Opin Infect Dis 2007;20:408–11.
   PubMedGoogle Scholar
• Valencia R, Arroyo LA, Conde M, Aldana JM, Torres MJ, Fernandez-Cuenca F, et al. Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital. Infect Control Hosp Epidemiol 2009;30:257–63.
   PubMed Web of Science ®Google Scholar
• Wareham DW, Bean DC, Khanna P, Hennessy EM, Krahe D, Ely A, et al. Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance. Eur J Clin Microbiol Infect Dis 2008; 27:607–12.
   PubMed Web of Science ®Google Scholar
• Anunnatsiri S, Tonsawan P. Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand. Southeast Asian J Trop Med Public Health 2011;42:693–703.
   PubMedGoogle Scholar
• Jung JY, Park MS, Kim SE, Park BH, Son JY, Kim EY, et al. Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit. BMC Infect Dis 2010;10:228.
   PubMed Web of Science ®Google Scholar
• Kim YJ, Kim SI, Hong KW, Kim YR, Park YJ, Kang MW. Risk factors for mortality in patients with carbapenem- resistant Acinetobacter baumannii bacteremia: impact of appropriate antimicrobial therapy. J Korean Med Sci 2012; 27:471–5.
   PubMed Web of Science ®Google Scholar
• Lee NY, Chang TC, Wu CJ, Chang CM, Lee HC, Chen PL, et al. Clinical manifestations, antimicrobial therapy, and prognostic factors of monomicrobial Acinetobacter baumannii complex bacteremia. J Infect 2010;61:219–27.
   PubMedGoogle Scholar
• Shih MJ, Lee NY, Lee HC, Chang CM, Wu CJ, Chen PL, et al. Risk factors of multidrug resistance in nosocomial bacteremia due to Acinetobacter baumannii: a case–control study. J Microbiol Immunol Infect 2008;41:118–23.
   PubMedGoogle Scholar
• Nunley DR, Bauldoff GS, Mangino JE, Pope-Harman AL. Mortality associated with Acinetobacter baumannii infections experienced by lung transplant recipients. Lung 2010;188:381–5.
   PubMedGoogle Scholar
• Kim YJ, Yoon JH, Kim SI, Hong KW, Kim JI, Choi JY, et al. High mortality associated with Acinetobacter species infection in liver transplant patients. Transplant Proc 2011; 43:2397–9.
   PubMedGoogle Scholar
• Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002;34:1094–7.
   PubMed Web of Science ®Google Scholar
• Cisneros JM, Rodriguez-Bano J. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect 2002;8:687–93.
   PubMed Web of Science ®Google Scholar
• Lee YT, Kuo SC, Yang SP, Lin YT, Tseng FC, Chen TL, et al. Impact of appropriate antimicrobial therapy on mortality associated with Acinetobacter baumannii bacteremia: relation to severity of infection. Clin Infect Dis 2012;55: 209–15.
   PubMed Web of Science ®Google Scholar
• Harbarth S, Nobre V, Pittet D. Does antibiotic selection impact patient outcome?. Clin Infect Dis 2007;44:87–93.
   PubMedGoogle Scholar